Bronchiectasis: An update

Maria Pappalettera; Stefano Aliberti; Paola Castellotti; Leonardo Ruvolo; Valeria Giunta; Francesco Blasi

doi:10.1111/j.1752-699X.2009.00131.x

Bronchiectasis: An update

Maria Pappalettera, Stefano Aliberti, Paola Castellotti, Leonardo Ruvolo, Valeria Giunta, Francesco Blasi

Research output: Contribution to journal › Article › peer-review

Abstract

Background and aims: Bronchiectasis is defined as an abnormal and irreversible dilatation of the bronchi, often associated with chronic productive cough, airway obstruction, and recurrent infections. Methods: MEDLINE data from 1978 to November 2008 was analysed. Search was limited to randomized control trials, clinical trials, meta-analysis, reviews published in English, using the keyword bronchiectasis. Results: The prevalence of bronchiectasis is unknown. However, prevalence seems to increase with age from 4.2 per 100 000 persons aged 18-34 years to 271.8 per 100 000 among those aged 75 years or older. Therapy is aimed to limit the cycle of infection and inflammation and to reduce the number of exacerbations, in order to improve quality of life. Conclusions: Bronchiectasis still remain a significant health problem. Further research is required to improve the management of this herterogeneous condition.

Original language	English
Pages (from-to)	126-134
Number of pages	9
Journal	Clinical Respiratory Journal
Volume	3
Issue number	3
DOIs	https://doi.org/10.1111/j.1752-699X.2009.00131.x
Publication status	Published - Jul 2009

Keywords

Bronchiectasis
Cystic fibrosis

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Immunology and Allergy
Genetics(clinical)

Access to Document

10.1111/j.1752-699X.2009.00131.x

Cite this

@article{4880d771c64c4f33ab150d93c7bb8cfb,

title = "Bronchiectasis: An update",

abstract = "Background and aims: Bronchiectasis is defined as an abnormal and irreversible dilatation of the bronchi, often associated with chronic productive cough, airway obstruction, and recurrent infections. Methods: MEDLINE data from 1978 to November 2008 was analysed. Search was limited to randomized control trials, clinical trials, meta-analysis, reviews published in English, using the keyword bronchiectasis. Results: The prevalence of bronchiectasis is unknown. However, prevalence seems to increase with age from 4.2 per 100 000 persons aged 18-34 years to 271.8 per 100 000 among those aged 75 years or older. Therapy is aimed to limit the cycle of infection and inflammation and to reduce the number of exacerbations, in order to improve quality of life. Conclusions: Bronchiectasis still remain a significant health problem. Further research is required to improve the management of this herterogeneous condition.",

keywords = "Bronchiectasis, Cystic fibrosis",

author = "Maria Pappalettera and Stefano Aliberti and Paola Castellotti and Leonardo Ruvolo and Valeria Giunta and Francesco Blasi",

year = "2009",

month = jul,

doi = "10.1111/j.1752-699X.2009.00131.x",

language = "English",

volume = "3",

pages = "126--134",

journal = "Clinical Respiratory Journal",

issn = "1752-6981",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Bronchiectasis

T2 - An update

AU - Pappalettera, Maria

AU - Aliberti, Stefano

AU - Castellotti, Paola

AU - Ruvolo, Leonardo

AU - Giunta, Valeria

AU - Blasi, Francesco

PY - 2009/7

Y1 - 2009/7

N2 - Background and aims: Bronchiectasis is defined as an abnormal and irreversible dilatation of the bronchi, often associated with chronic productive cough, airway obstruction, and recurrent infections. Methods: MEDLINE data from 1978 to November 2008 was analysed. Search was limited to randomized control trials, clinical trials, meta-analysis, reviews published in English, using the keyword bronchiectasis. Results: The prevalence of bronchiectasis is unknown. However, prevalence seems to increase with age from 4.2 per 100 000 persons aged 18-34 years to 271.8 per 100 000 among those aged 75 years or older. Therapy is aimed to limit the cycle of infection and inflammation and to reduce the number of exacerbations, in order to improve quality of life. Conclusions: Bronchiectasis still remain a significant health problem. Further research is required to improve the management of this herterogeneous condition.

AB - Background and aims: Bronchiectasis is defined as an abnormal and irreversible dilatation of the bronchi, often associated with chronic productive cough, airway obstruction, and recurrent infections. Methods: MEDLINE data from 1978 to November 2008 was analysed. Search was limited to randomized control trials, clinical trials, meta-analysis, reviews published in English, using the keyword bronchiectasis. Results: The prevalence of bronchiectasis is unknown. However, prevalence seems to increase with age from 4.2 per 100 000 persons aged 18-34 years to 271.8 per 100 000 among those aged 75 years or older. Therapy is aimed to limit the cycle of infection and inflammation and to reduce the number of exacerbations, in order to improve quality of life. Conclusions: Bronchiectasis still remain a significant health problem. Further research is required to improve the management of this herterogeneous condition.

KW - Bronchiectasis

KW - Cystic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=68849104079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849104079&partnerID=8YFLogxK

U2 - 10.1111/j.1752-699X.2009.00131.x

DO - 10.1111/j.1752-699X.2009.00131.x

M3 - Article

C2 - 20298395

AN - SCOPUS:68849104079

SN - 1752-6981

VL - 3

SP - 126

EP - 134

JO - Clinical Respiratory Journal

JF - Clinical Respiratory Journal

IS - 3

ER -

Bronchiectasis: An update

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this